Meadow Creek Investment Management’s Mesa Laboratories MLAB Stock Holding History

Meadow Creek Investment Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$99K	Buy	+418	New	+$96.6K	﹤0.01%	1205

Other funds holding MLAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Meadow Creek Investment Management's MLAB Position: Q3 2019 in Review

Meadow Creek Investment Management opened a new position in Mesa Laboratories (MLAB) in Q3 2019: 418 shares worth $99K. The stake represents ﹤0.01% of the portfolio and ranks #1205 among its holdings.

144 funds tracked by Wall St. Rank hold MLAB as of Q3 2019.

Meadow Creek Investment Management held 418 shares of Mesa Laboratories worth $99K as of Q3 2019.
Mesa Laboratories was a new Meadow Creek Investment Management position in Q3 2019.
Mesa Laboratories made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1205 holding.
144 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.